Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
about
Stinging insect allergy: current perspectives on venom immunotherapyLong-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Comparing the ability of molecular diagnosis and CAP-inhibition in identifying the really causative venom in patients with positive tests to Vespula and Polistes species.Fatal Anaphylaxis: Mortality Rate and Risk Factors.Current state of follow-up care for patients with Hymenoptera venom anaphylaxis in southwest Germany: Major impact of early information.
P2860
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@en
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@nl
type
label
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@en
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@nl
prefLabel
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@en
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@nl
P2093
P2860
P356
P1433
P1476
Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?
@en
P2093
J Hockenhull
M Elremeli
P2860
P304
P356
10.1111/ALL.12210
P577
2013-10-01T00:00:00Z